The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas

Cancer Research

Volumn 62, Issue 8, 2002, Pages 2398-2405

  Finelli, Palma ^a   Pierantoni, Giovanna Maria ^b   Giardino, Daniela ^a   Losa, Marco ^c   Rodeschini, Ornella ^a   Fedele, Monica ^b   Valtorta, Emanuele ^a   Mortini, Pietro ^c   Croce, Carlo M ^d   Larizza, Lidia ^a,e   Fusco, Alfredo ^b  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER CELL CULTURE; CHROMOSOME 12Q; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENE OVEREXPRESSION; GENE REARRANGEMENT; HIGH MOBILITY GROUP A2 GENE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROLACTINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TETRASOMY; TRANSGENIC MOUSE; TRISOMY 12; WESTERN BLOTTING;

ADOLESCENT; ADULT; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HMGA2 PROTEIN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PROLACTINOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0037089558     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Tumors of the pituitary gland
2. Clonal origin of pituitary adenomas
3. Age-related and gender-related occurrence of pituitary adenomas
4. Transsphenoidal microsurgical removal of 250 pituitary adenomas
5. Monoclonality of corticotroph macroadenomas in Cushing's disease
6. Incidence, pathology, and recurrence of pituitary adenomas: Study of 647 unselected surgical cases
7. G-proteins: Transducers of receptors-generated signals
8. The cytogenesis and pathogenesis of pituitary adenomas
9. Infrequent mutations of p27 gene and trisomy 12 in a subset of human pituitary adenomas
10. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis
11. Alternative processing of mRNA's coding for human HMG 1 and HMG Y proteins
12. A poly(dA-dT) upstream activating sequence binds high-mobility group 1 protein and contributes to lymphotoxin (tumor necrosis factor-β) gene regulation
13. HMG domain proteins: Architectural elements in the assembly of nucleoprotein structure
14. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C
15. Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation
16. The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis
17. High level expression of the HMGI(Y) gene during embryonic development
18. The expression of high mobility group HMGI(Y) proteins correlates with malignant phenotype of human thyroid neoplasias
19. Detection of high mobility group I HMGI(Y) proteins in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma
20. Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization
21. Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix
22. Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins
23. Analysis of high mobility group I(Y) protein expression in colorectal tumors
24. High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases
25. Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins
26. Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism
27. Adenovirus-mediated suppression of the HMGAY protein synthesis as a potential therapy of human malignant neoplasias
28. Cytogenetic study of pituitary adenomas
29. Non random trisomies of chromosomes 5, 8 and 12 in the prolactinoma subtype of pituitary adenomas: Conventional cytogenetics and interphase FISH study
30. An improved approach for construction of bacterial artificial chromosome libraries
31. Regional fine mapping of the multiple-aberration region involved in uterine leiomyoma, lipoma, and pleomorphic adenoma of the salivary gland to 12q15
32. A human α satellite DNA subset specific for chromosome 12
33. High resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones
34. Chromosome analysis by non-isotopic in situ hybridization
35. A 12q13 translocation involving the HMGI-C gene in one case of Richter's transformation of a chronic lymphocytic leukaemia
36. Nerve growth factor suppresses the transforming phenotype of human prolactinomas